top of page
Foto do escritorAtom Black

CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PFIZER.

After a judicial order, Pfizer is forced to reveal their adverse reports on their vaccine, which they wanted to hide from you for 75 years.



Here are just some of the adverse effects that happened during their own trials!


Please google some of these adverse effects and see for your self what has been hidden from and what you were deceived in taking.


1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5'nucleotidase increased;Acoustic

neuritis;Acquired C1 inhibitor deficiency;Acquired epidermolysis bullosa;Acquired epileptic

aphasia;Acute cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute

encephalitis with refractory, repetitive partial seizures;Acute febrile neutrophilic

dermatosis;Acute flaccid myelitis;Acute haemorrhagic leukoencephalitis;Acute

haemorrhagic oedema of infancy;Acute kidney injury;Acute macular outer retinopathy;Acute

motor axonal neuropathy;Acute motor-sensory axonal neuropathy;Acute myocardial

infarction;Acute respiratory distress syndrome;Acute respiratory failure;Addison's

disease;Administration site thrombosis;Administration site vasculitis;Adrenal

thrombosis;Adverse event following immunisation;Ageusia;Agranulocytosis;Air

embolism;Alanine aminotransferase abnormal;Alanine aminotransferase increased;Alcoholic

seizure;Allergic bronchopulmonary mycosis;Allergic oedema;Alloimmune

hepatitis;Alopecia areata;Alpers disease;Alveolar proteinosis;Ammonia abnormal;Ammonia

increased;Amniotic cavity infection;Amygdalohippocampectomy;Amyloid

arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic reaction;Anaphylactic

shock;Anaphylactic transfusion reaction;Anaphylactoid reaction;Anaphylactoid

shock;Anaphylactoid syndrome of pregnancy;Angioedema;Angiopathic

neuropathy;Ankylosing spondylitis;Anosmia;Antiacetylcholine receptor antibody

positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody positive;Anti-basal ganglia

antibody positive;Anti-cyclic citrullinated peptide antibody positive;Anti-epithelial antibody

positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody positive;AntiGAD antibody negative;Anti-GAD antibody positive;Anti-ganglioside antibody

positive;Antigliadin antibody positive;Anti-glomerular basement membrane antibody

positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA synthetase antibody

positive;Anti-HLA antibody test positive;Anti-IA2 antibody positive;Anti-insulin antibody

increased;Anti-insulin antibody positive;Anti-insulin receptor antibody increased;Antiinsulin receptor antibody positive;Anti-interferon antibody negative;Anti-interferon antibody

positive;Anti-islet cell antibody positive;Antimitochondrial antibody positive;Anti-muscle

specific kinase antibody positive;Anti-myelin-associated glycoprotein antibodies

positive;Anti-myelin-associated glycoprotein associated polyneuropathy;Antimyocardial

antibody positive;Anti-neuronal antibody positive;Antineutrophil cytoplasmic antibody

increased;Antineutrophil cytoplasmic antibody positive;Anti-neutrophil cytoplasmic

antibody positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody

increased;Antinuclear antibody positive;Antiphospholipid antibodies

positive;Antiphospholipid syndrome;Anti-platelet antibody positive;Anti-prothrombin

antibody positive;Antiribosomal P antibody positive;Anti-RNA polymerase III antibody

positive;Anti-saccharomyces cerevisiae antibody test positive;Anti-sperm antibody

positive;Anti-SRP antibody positive;Antisynthetase syndrome;Anti-thyroid antibody

positive;Anti-transglutaminase antibody increased;Anti-VGCC antibody positive;AntiVGKC antibody positive;Anti-vimentin antibody positive;Antiviral prophylaxis;Antiviral

treatment;Anti-zinc transporter 8 antibody positive;Aortic embolus;Aortic

thrombosis;Aortitis;Aplasia pure red cell;Aplastic anaemia;Application site

thrombosis;Application site vasculitis;Arrhythmia;Arterial bypass occlusion;Arterial bypass

thrombosis;Arterial thrombosis;Arteriovenous fistula thrombosis;Arteriovenous graft site

stenosis;Arteriovenous graft thrombosis;Arteritis;Arteritis

Page 30

090177e196ea1800\Approved\Approved On: 30-A

pr-2021 09:26 (GMT)

FDA-CBER-2021-5683-0000083

BNT162b2

5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports

CONFIDENTIAL

Page 2

coronary;Arthralgia;Arthritis;Arthritis enteropathic;Ascites;Aseptic cavernous sinus

thrombosis;Aspartate aminotransferase abnormal;Aspartate aminotransferase

increased;Aspartate-glutamate-transporter deficiency;AST to platelet ratio index

increased;AST/ALT ratio abnormal;Asthma;Asymptomatic COVID19;Ataxia;Atheroembolism;Atonic seizures;Atrial thrombosis;Atrophic thyroiditis;Atypical

benign partial epilepsy;Atypical pneumonia;Aura;Autoantibody positive;Autoimmune

anaemia;Autoimmune aplastic anaemia;Autoimmune arthritis;Autoimmune blistering

disease;Autoimmune cholangitis;Autoimmune colitis;Autoimmune demyelinating

disease;Autoimmune dermatitis;Autoimmune disorder;Autoimmune

encephalopathy;Autoimmune endocrine disorder;Autoimmune enteropathy;Autoimmune eye

disorder;Autoimmune haemolytic anaemia;Autoimmune heparin-induced

thrombocytopenia;Autoimmune hepatitis;Autoimmune hyperlipidaemia;Autoimmune

hypothyroidism;Autoimmune inner ear disease;Autoimmune lung disease;Autoimmune

lymphoproliferative syndrome;Autoimmune myocarditis;Autoimmune myositis;Autoimmune

nephritis;Autoimmune neuropathy;Autoimmune neutropenia;Autoimmune

pancreatitis;Autoimmune pancytopenia;Autoimmune pericarditis;Autoimmune

retinopathy;Autoimmune thyroid disorder;Autoimmune thyroiditis;Autoimmune

uveitis;Autoinflammation with infantile enterocolitis;Autoinflammatory disease;Automatism

epileptic;Autonomic nervous system imbalance;Autonomic seizure;Axial

spondyloarthritis;Axillary vein thrombosis;Axonal and demyelinating

polyneuropathy;Axonal neuropathy;Bacterascites;Baltic myoclonic epilepsy;Band

sensation;Basedow's disease;Basilar artery thrombosis;Basophilopenia;B-cell

aplasia;Behcet's syndrome;Benign ethnic neutropenia;Benign familial neonatal

convulsions;Benign familial pemphigus;Benign rolandic epilepsy;Beta-2 glycoprotein

antibody positive;Bickerstaff's encephalitis;Bile output abnormal;Bile output

decreased;Biliary ascites;Bilirubin conjugated abnormal;Bilirubin conjugated

increased;Bilirubin urine present;Biopsy liver abnormal;Biotinidase deficiency;Birdshot

chorioretinopathy;Blood alkaline phosphatase abnormal;Blood alkaline phosphatase

increased;Blood bilirubin abnormal;Blood bilirubin increased;Blood bilirubin unconjugated

increased;Blood cholinesterase abnormal;Blood cholinesterase decreased;Blood pressure

decreased;Blood pressure diastolic decreased;Blood pressure systolic decreased;Blue toe

syndrome;Brachiocephalic vein thrombosis;Brain stem embolism;Brain stem

thrombosis;Bromosulphthalein test abnormal;Bronchial oedema;Bronchitis;Bronchitis

mycoplasmal;Bronchitis viral;Bronchopulmonary aspergillosis allergic;Bronchospasm;BuddChiari syndrome;Bulbar palsy;Butterfly rash;C1q nephropathy;Caesarean section;Calcium

embolism;Capillaritis;Caplan's syndrome;Cardiac amyloidosis;Cardiac arrest;Cardiac

failure;Cardiac failure acute;Cardiac sarcoidosis;Cardiac ventricular thrombosis;Cardiogenic

shock;Cardiolipin antibody positive;Cardiopulmonary failure;Cardio-respiratory

arrest;Cardio-respiratory distress;Cardiovascular insufficiency;Carotid arterial

embolus;Carotid artery thrombosis;Cataplexy;Catheter site thrombosis;Catheter site

vasculitis;Cavernous sinus thrombosis;CDKL5 deficiency disorder;CEC syndrome;Cement

embolism;Central nervous system lupus;Central nervous system vasculitis;Cerebellar artery

thrombosis;Cerebellar embolism;Cerebral amyloid angiopathy;Cerebral arteritis;Cerebral

artery embolism;Cerebral artery thrombosis;Cerebral gas embolism;Cerebral

microembolism;Cerebral septic infarct;Cerebral thrombosis;Cerebral venous sinus

thrombosis;Cerebral venous thrombosis;Cerebrospinal thrombotic

Page 31

090177e196ea1800\Approved\Approved On: 30-A

pr-2021 09:26 (GMT)

FDA-CBER-2021-5683-0000084

BNT162b2

5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports

CONFIDENTIAL

Page 3

tamponade;Cerebrovascular accident;Change in seizure presentation;Chest discomfort;ChildPugh-Turcotte score abnormal;Child-Pugh-Turcotte score

increased;Chillblains;Choking;Choking sensation;Cholangitis sclerosing;Chronic

autoimmune glomerulonephritis;Chronic cutaneous lupus erythematosus;Chronic fatigue

syndrome;Chronic gastritis;Chronic inflammatory demyelinating

polyradiculoneuropathy;Chronic lymphocytic inflammation with pontine perivascular

enhancement responsive to steroids;Chronic recurrent multifocal osteomyelitis;Chronic

respiratory failure;Chronic spontaneous urticaria;Circulatory collapse;Circumoral

oedema;Circumoral swelling;Clinically isolated syndrome;Clonic convulsion;Coeliac

disease;Cogan's syndrome;Cold agglutinins positive;Cold type haemolytic

anaemia;Colitis;Colitis erosive;Colitis herpes;Colitis microscopic;Colitis ulcerative;Collagen

disorder;Collagen-vascular disease;Complement factor abnormal;Complement factor C1

decreased;Complement factor C2 decreased;Complement factor C3 decreased;Complement

factor C4 decreased;Complement factor decreased;Computerised tomogram liver

abnormal;Concentric sclerosis;Congenital anomaly;Congenital bilateral perisylvian

syndrome;Congenital herpes simplex infection;Congenital myasthenic syndrome;Congenital

varicella infection;Congestive hepatopathy;Convulsion in childhood;Convulsions

local;Convulsive threshold lowered;Coombs positive haemolytic anaemia;Coronary artery

disease;Coronary artery embolism;Coronary artery thrombosis;Coronary bypass

thrombosis;Coronavirus infection;Coronavirus test;Coronavirus test negative;Coronavirus

test positive;Corpus callosotomy;Cough;Cough variant asthma;COVID-19;COVID-19

immunisation;COVID-19 pneumonia;COVID-19 prophylaxis;COVID-19 treatment;Cranial

nerve disorder;Cranial nerve palsies multiple;Cranial nerve paralysis;CREST

syndrome;Crohn's disease;Cryofibrinogenaemia;Cryoglobulinaemia;CSF oligoclonal band

present;CSWS syndrome;Cutaneous amyloidosis;Cutaneous lupus erythematosus;Cutaneous

sarcoidosis;Cutaneous vasculitis;Cyanosis;Cyclic neutropenia;Cystitis interstitial;Cytokine

release syndrome;Cytokine storm;De novo purine synthesis inhibitors associated acute

inflammatory syndrome;Death neonatal;Deep vein thrombosis;Deep vein thrombosis

postoperative;Deficiency of bile secretion;Deja vu;Demyelinating

polyneuropathy;Demyelination;Dermatitis;Dermatitis bullous;Dermatitis

herpetiformis;Dermatomyositis;Device embolisation;Device related thrombosis;Diabetes

mellitus;Diabetic ketoacidosis;Diabetic mastopathy;Dialysis amyloidosis;Dialysis membrane

reaction;Diastolic hypotension;Diffuse vasculitis;Digital pitting scar;Disseminated

intravascular coagulation;Disseminated intravascular coagulation in newborn;Disseminated

neonatal herpes simplex;Disseminated varicella;Disseminated varicella zoster vaccine virus

infection;Disseminated varicella zoster virus infection;DNA antibody positive;Double cortex

syndrome;Double stranded DNA antibody positive;Dreamy state;Dressler's syndrome;Drop

attacks;Drug withdrawal convulsions;Dyspnoea;Early infantile epileptic encephalopathy with

burst-suppression;Eclampsia;Eczema herpeticum;Embolia cutis medicamentosa;Embolic

cerebellar infarction;Embolic cerebral infarction;Embolic pneumonia;Embolic

stroke;Embolism;Embolism arterial;Embolism venous;Encephalitis;Encephalitis

allergic;Encephalitis autoimmune;Encephalitis brain stem;Encephalitis

haemorrhagic;Encephalitis periaxialis diffusa;Encephalitis post

immunisation;Encephalomyelitis;Encephalopathy;Endocrine disorder;Endocrine

ophthalmopathy;Endotracheal intubation;Enteritis;Enteritis leukopenic;Enterobacter

pneumonia;Enterocolitis;Enteropathic spondylitis;Eosinopenia;Eosinophilic

Page 32

090177e196ea1800\Approved\Approved On: 30-A

pr-2021 09:26 (GMT)

FDA-CBER-2021-5683-0000085

BNT162b2

5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports

CONFIDENTIAL

Page 4

fasciitis;Eosinophilic granulomatosis with polyangiitis;Eosinophilic

oesophagitis;Epidermolysis;Epilepsy;Epilepsy surgery;Epilepsy with myoclonic-atonic

seizures;Epileptic aura;Epileptic psychosis;Erythema;Erythema induratum;Erythema

multiforme;Erythema nodosum;Evans syndrome;Exanthema subitum;Expanded disability

status scale score decreased;Expanded disability status scale score increased;Exposure to

communicable disease;Exposure to SARS-CoV-2;Eye oedema;Eye pruritus;Eye

swelling;Eyelid oedema;Face oedema;Facial paralysis;Facial paresis;Faciobrachial dystonic

seizure;Fat embolism;Febrile convulsion;Febrile infection-related epilepsy syndrome;Febrile

neutropenia;Felty's syndrome;Femoral artery embolism;Fibrillary

glomerulonephritis;Fibromyalgia;Flushing;Foaming at mouth;Focal cortical resection;Focal

dyscognitive seizures;Foetal distress syndrome;Foetal placental thrombosis;Foetor

hepaticus;Foreign body embolism;Frontal lobe epilepsy;Fulminant type 1 diabetes

mellitus;Galactose elimination capacity test abnormal;Galactose elimination capacity test

decreased;Gamma-glutamyltransferase abnormal;Gamma-glutamyltransferase

increased;Gastritis

64 visualizações0 comentário

Posts recentes

Ver tudo

コメント


bottom of page